Adage Capital Partners GP L.L.C. Sells 22,873 Shares of Encompass Health Co. (NYSE:EHC)

Adage Capital Partners GP L.L.C. trimmed its position in Encompass Health Co. (NYSE:EHC - Free Report) by 11.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 184,062 shares of the company's stock after selling 22,873 shares during the period. Adage Capital Partners GP L.L.C. owned 0.18% of Encompass Health worth $16,998,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its position in Encompass Health by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock valued at $59,544,000 after purchasing an additional 4,345 shares during the last quarter. Central Pacific Bank Trust Division raised its holdings in Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company's stock valued at $295,000 after buying an additional 418 shares during the last quarter. Merit Financial Group LLC acquired a new stake in Encompass Health during the 4th quarter worth approximately $374,000. MassMutual Private Wealth & Trust FSB grew its holdings in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the last quarter. Finally, US Bancorp DE raised its stake in shares of Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after acquiring an additional 121 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company's stock.

Wall Street Analyst Weigh In

EHC has been the subject of several analyst reports. Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Friday. Barclays upped their target price on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, KeyCorp upped their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday. Nine investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Encompass Health presently has a consensus rating of "Buy" and an average target price of $113.14.

Encompass Health Stock Performance

NYSE:EHC opened at $113.33 on Friday. The firm has a market capitalization of $11.41 billion, a P/E ratio of 25.41, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a twelve month low of $82.38 and a twelve month high of $114.38. The company has a fifty day moving average of $100.08 and a 200-day moving average of $98.54. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were paid a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.60%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.